Stemline Therapeutics Inc - New York City, New York 10022

Stemline Therapeutics Inc is categorized under in New York City, NY .

Business Name: Stemline Therapeutics Inc
Contact Person: Ivan Bergstein, Chief Executive Officer
Address: 750 Lexington Avenue Floor 6, New York City, New York 10022
Phone Number: (646) 502-2310
Website Address: stemline.com
Annual Revenue (USD): Unknown
Founding Year: 2003
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 3254120
Share This Business:
Related Businesses: Lightlake Therapeutics Inc - New York City, NY 10022
Krele LLC - New York City, NY 10022
Melinta Pharmaceuticals Inc - New York City, NY 10022
Aoi Pharma Inc - New York City, NY 10022
Niobe Ventures LLC - New York City, NY 10022
Ohr Pharmaceutical Inc - New York City, NY 10022
Bristol-Myers Squibb Company - New York City, NY 10022
Forest Laboratories Inc - New York City, NY 10022
Keryx Biopharmaceuticals Inc - New York City, NY 10022
Tonix Pharmaceuticals Inc - New York City, NY 10022
Danube Pharmaceuticals Inc - New York City, NY 10022

The company Stemline Therapeutics Inc provides BOTH services in the form of from its headquarters in New York. 1 to 4 employees work for Stemline Therapeutics Inc, and the business now earns Unknown per annum.

Stemline Therapeutics Inc was launched in 2003 and is classified under SIC code and category 2834 , and NAICS number and grouping 3254120 . To contact Stemline Therapeutics Inc, please call Ivan Bergstein, Chief Executive Officer with the phone number (646) 502-2310 or visit its headquarters at 750 Lexington Avenue Floor 6 in New York City, New York 10022.

The location of the headquarters can also be found using the coordinates 40.762509,-73.968061. Read more details about this business on the webpage stemline.com or follow the company’s social media accounts, on Twitter and on Facebook.